Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check6 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check13 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check41 days agoChange DetectedA 403 Forbidden error message is now shown, along with basic site chrome, instead of the study record content and related documents. This makes the study information currently inaccessible to users.SummaryDifference19%

- Check62 days agoChange DetectedThe page footer shows an updated revision tag from v3.6.5 to v3.6.6, signaling a system/template update without modifications to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now shows an error/unavailable message instead of the study record for the NCT04419610 entry, preventing access to the study details until the issue is resolved.SummaryDifference18%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.